| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2014/10/21 | 21 : 00 | PR Newswire (US) | Aptose Biosciences Announces Approval for Listing on the NASDAQ Capital Market Shares to Begin Trading Under the Symbol APTO | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/10/21 | 21 : 00 | PR Newswire (Canada) | Aptose Biosciences Announces Approval for Listing on the NASDAQ Capital Market Shares to Begin Trading Under the Symbol APTO | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/10/03 | 20 : 00 | PR Newswire (US) | Aptose Biosciences to Present at the 2014 BIO Investor Forum | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/10/03 | 20 : 00 | PR Newswire (Canada) | Aptose Biosciences to Present at the 2014 BIO Investor Forum | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/10/02 | 06 : 16 | PR Newswire (Canada) | Aptose Biosciences Announces Reverse Stock Split | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/10/02 | 06 : 16 | PR Newswire (US) | Aptose Biosciences Announces Reverse Stock Split | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/09/29 | 21 : 30 | PR Newswire (US) | Aptose Biosciences Joins The Leukemia & Lymphoma Society's Groundbreaking Beat AML Research Initiative with Oregon Health & S... | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/09/29 | 21 : 30 | PR Newswire (Canada) | Aptose Biosciences Joins The Leukemia & Lymphoma Society's Groundbreaking Beat AML Research Initiative with Oregon Health & S... | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/09/25 | 22 : 48 | PR Newswire (US) | Aptose Biosciences to Present at Upcoming Investor Conferences | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/09/25 | 22 : 48 | PR Newswire (Canada) | Aptose Biosciences to Present at Upcoming Investor Conferences | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/09/08 | 20 : 00 | PR Newswire (US) | Aptose Biosciences Recruits Stephen B. Howell, M.D. to Act in the Capacity of Chief Medical Officer | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/09/08 | 20 : 00 | PR Newswire (Canada) | Aptose Biosciences Recruits Stephen B. Howell, M.D. to Act in the Capacity of Chief Medical Officer | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/09/02 | 20 : 00 | PR Newswire (US) | Lorus Therapeutics Implements Name Change to Aptose Biosciences | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/09/02 | 20 : 00 | PR Newswire (Canada) | Lorus Therapeutics Implements Name Change to Aptose Biosciences | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/08/20 | 05 : 00 | PR Newswire (US) | Lorus Therapeutics Announces Results of Annual and Special Meeting of Shareholders | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/08/20 | 05 : 00 | PR Newswire (Canada) | Lorus Therapeutics Announces Results of Annual and Special Meeting of Shareholders | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/08/07 | 20 : 00 | PR Newswire (US) | Lorus Therapeutics to Present at the Canaccord Genuity 34th Annual Growth Conference | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/08/07 | 20 : 00 | PR Newswire (Canada) | Lorus Therapeutics to Present at the Canaccord Genuity 34th Annual Growth Conference | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/07/28 | 20 : 00 | PR Newswire (US) | Lorus Therapeutics Receives FDA Clearance of IND to Initiate LOR-253 Clinical Program in Patients with AML, MDS and other Blo... | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/07/28 | 20 : 00 | PR Newswire (Canada) | Lorus Therapeutics Receives FDA Clearance of IND to Initiate LOR-253 Clinical Program in Patients with AML, MDS and other Blo... | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/07/16 | 05 : 46 | PR Newswire (US) | Lorus Therapeutics Reports Results for the Fourth Quarter and Full Year Ended May 31, 2014 | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/07/16 | 05 : 46 | PR Newswire (Canada) | Lorus Therapeutics Reports Results for the Fourth Quarter and Full Year Ended May 31, 2014 | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/07/16 | 05 : 28 | PR Newswire (US) | Lorus Therapeutics Proposes Name Change to "APTOSE BIOSCIENCES" and Share Consolidation for Potential NASDAQ Listing | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/07/16 | 05 : 28 | PR Newswire (Canada) | Lorus Therapeutics Proposes Name Change to "APTOSE BIOSCIENCES" and Share Consolidation for Potential NASDAQ Listing | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/07/10 | 20 : 00 | PR Newswire (US) | Lorus Therapeutics To Host Fourth Quarter and Year End 2014 Financial Results Conference Call and Webcast | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/07/10 | 20 : 00 | PR Newswire (Canada) | Lorus Therapeutics To Host Fourth Quarter and Year End 2014 Financial Results Conference Call and Webcast | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/06/19 | 20 : 00 | PR Newswire (US) | Lorus Therapeutics to Present at the 9th JMP Securities Healthcare Conference | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/06/19 | 20 : 00 | PR Newswire (Canada) | Lorus Therapeutics to Present at the 9th JMP Securities Healthcare Conference | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/06/16 | 20 : 00 | PR Newswire (Canada) | Lorus Therapeutics to Present at the 2014 Bloom Burton & Co. Healthcare Investor Conference | AMEX:LRP | Lorus Therapeutics, (New) |
| 2014/06/16 | 20 : 00 | PR Newswire (US) | Lorus Therapeutics to Present at the 2014 Bloom Burton & Co. Healthcare Investor Conference | AMEX:LRP | Lorus Therapeutics, (New) |